Menarini Group Reports Promising Elacestrant-Capivasertib Results in Metastatic Breast Cancer at ASCO 2026
FLORENCE, Italy and NEW YORK, May 28, 2026 Menarini Group and its wholly owned subsidiary Stemline Therapeutics have announced...
Anti PD-1 Therapy
Advertisement
TECVAYLI Extends Survival in Relapsed Multiple Myeloma
CHICAGO, Illinois, May 29, 2026 Johnson & Johnson has reported landmark results from the pivotal Phase 3 MajesTEC-9 study,...
Akeso’s Ivonescimab Cuts Death Risk by 34% in NSCLC
CHICAGO, Illinois, May 31, 2026 Akeso, Inc. has announced landmark results from the pivotal Phase III HARMONi-6 trial, demonstrating...
Dizal Highlights Promising NSCLC Therapies at ASCO 2026
May 31, 2026 – Chicago, Illinois, USA Dizal has unveiled encouraging clinical findings for two innovative non-small cell lung...
Advertisement
